相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase/Akt Serine/Threonine Kinase and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma
Manali Dimri et al.
HEPATOLOGY (2020)
Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
Yan-Lin Huang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Gandhi T. K. Boopathy et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting
Sawsan Elattar et al.
FASEB JOURNAL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
Zhong Xu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.
Anthony B. El-Khoueiry et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
Dimitrios Dimitroulis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Implication of the Hedgehog pathway in hepatocellular carcinoma
Carminia Maria Della Corte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
Sufang Yang et al.
ONCOLOGY LETTERS (2017)
Three-dimensional structural analysis reveals a Cdk5-mediated kinase cascade regulating hepatic biliary network branching in zebrafish
Manali Dimri et al.
DEVELOPMENT (2017)
The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
Xuan Shi et al.
CANCER LETTERS (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells
Xia Sheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
Xue Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler et al.
TRANSPLANTATION (2016)
Sonic hedgehog pathway inhibitor mitigates mouse hepatocellular carcinoma
Kuo-Shyang Jeng et al.
AMERICAN JOURNAL OF SURGERY (2015)
Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
Kyung-Ju Choi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
S. J. Thomas et al.
BRITISH JOURNAL OF CANCER (2015)
Ligand and Structure Based Models for the Identification of Beta 2 Adrenergic Receptor Antagonists
Jayadev Joshi et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2015)
Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
Cheolhee Won et al.
HEPATOLOGY (2015)
New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions
Makoto Chuma et al.
HEPATOLOGY RESEARCH (2015)
Todralazine Protects Zebrafish from Lethal Effects of Ionizing Radiation: Role of Hematopoietic Cell Expansion
Manali Dimri et al.
ZEBRAFISH (2015)
Review of angiogenesis in hepatocellular carcinoma
Jun Muto et al.
HEPATOLOGY RESEARCH (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy
Chuan Chen et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Therapeutic Targeting of the JAK/STAT Pathway
Saara Aittomaki et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Antitumor Effects in Hepatocarcinoma of lsoform-Selective Inhibition of HDAC2
Yun-Han Lee et al.
CANCER RESEARCH (2014)
Molecular Therapies in Hepatocellular Carcinoma: What Can We Target?
Roberto Galuppo et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo
Chakrabhavi Dhananjaya Mohan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
Hong-Qiang Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
Ming Liu et al.
PROTEIN & CELL (2014)
Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro
Chuanming Xu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
Han Chong Toh et al.
CANCER (2013)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
Hedgehog Signaling Pathway Regulates Autophagy in Human Hepatocellular Carcinoma Cells
Ying Wang et al.
HEPATOLOGY (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
Ann-Lii Cheng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Armando Santoro et al.
LANCET ONCOLOGY (2013)
Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma
Zhengyu Wei et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2013)
Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Alla Arzumanyan et al.
CANCER RESEARCH (2012)
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Nicole Grabinski et al.
MOLECULAR CANCER (2012)
Hepatocellular carcinoma reply
Alejandro Forner et al.
LANCET (2012)
Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
Qian Zhou et al.
FUTURE ONCOLOGY (2011)
Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
Naoki Oishi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
Feng Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A phase I study of AVE1642, a human monoclonal antibody-blocking insulin-like growth factor-1 receptor (IGF-1R), given as a single agent and in combination with sorafenib as first-line therapy in patients with advanced hepatocellular carcinoma (HCC).
S. J. Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC)
G. K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The changing pattern of epidemiology in hepatocellular carcinoma
Helena Nordenstedt et al.
DIGESTIVE AND LIVER DISEASE (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
Fabio Farinati et al.
BMC CANCER (2009)
Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
Ke Wu et al.
CANCER RESEARCH (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Hepatocellular carcinoma and the ubiquitin-proteasome system
Simon P. Dawson
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Live or let die: E2F1 and PI3K pathways intersect to make life or death decisions
Brian David Dyniacht
CANCER CELL (2008)
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer
Sara Ladu et al.
GASTROENTEROLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
W. Song et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent
Valentina A. Schmidt et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Wnt/beta-catenin signaling mediates oval cell response in rodents
Udayan Apte et al.
HEPATOLOGY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis
Zhaorui Lian et al.
HEPATOLOGY (2007)
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma
David Semela et al.
JOURNAL OF HEPATOLOGY (2007)
Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells
Youngsoo Kim et al.
CANCER RESEARCH (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation
Wolfgang Sieghart et al.
TRANSPLANTATION (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Hepatocellular carcinoma development in cirrhosis
Hiroaki Okuda
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2007)
The Hippo Pathway in Human Upper Gastrointestinal Dysplasia and Carcinoma: A Novel Oncogenic Pathway
Dora M. Lam-Himlin et al.
JOURNAL OF GASTROINTESTINAL CANCER (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway
Jared A. Gollob et al.
SEMINARS IN ONCOLOGY (2006)
Activation of the hedgehog pathway in human hepatocellular carcinomas
Shuhong Huang et al.
CARCINOGENESIS (2006)
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
JK Sicklick et al.
CARCINOGENESIS (2006)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC
DF Calvisi et al.
GASTROENTEROLOGY (2006)
New therapies for hepatocellular carcinoma
M. A. Avila et al.
ONCOGENE (2006)
Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma
E Yasuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Opportunities for targeted therapies in hepatocellular carcinoma
MB Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hepatocellular carcinoma: Molecular pathways and new therapeutic targets
LR Roberts et al.
SEMINARS IN LIVER DISEASE (2005)
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
LA Ormandy et al.
CANCER RESEARCH (2005)
Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target
TK Lee et al.
CARCINOGENESIS (2005)
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
D Strumberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II
P Lund et al.
CANCER LETTERS (2004)
Regulating the p53 system through ubiquitination
YL Yang et al.
ONCOGENE (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
Inhibitors of cytokine signal transduction
S Wormald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications
AM Burger et al.
EUROPEAN JOURNAL OF CANCER (2004)
An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis
C Alexia et al.
BIOCHEMICAL PHARMACOLOGY (2004)
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
KH Emami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth
L You et al.
CANCER RESEARCH (2004)
mTOR and P70S6 kinase expression in primary liver neoplasms
F Sahin et al.
CLINICAL CANCER RESEARCH (2004)
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
M Höpfner et al.
JOURNAL OF HEPATOLOGY (2004)
Angiogenesis and hepatocellular carcinoma
D Semela et al.
JOURNAL OF HEPATOLOGY (2004)
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
EMJ Boon et al.
BRITISH JOURNAL OF CANCER (2004)
Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells
J Halaschek-Wiener et al.
CELLULAR SIGNALLING (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma
RTP Poon et al.
BRITISH JOURNAL OF SURGERY (2004)
Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
E Hattori et al.
HEPATOLOGY RESEARCH (2003)
Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair
YS Dong et al.
MOLECULAR CELL (2003)
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
DM Berman et al.
NATURE (2003)
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
H Huynh et al.
BMC GASTROENTEROLOGY (2003)
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
F Chang et al.
LEUKEMIA (2003)
Caught up in a Wnt storm: Wnt signaling in cancer
RH Giles et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2003)
Hedgehog signal transduction: recent findings
K Nybakken et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
SOCS proteins: Negative regulators of cytokine signaling
DL Krebs et al.
STEM CELLS (2001)
Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens
T Shimamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
分享论文
